BioPharma
30 March, 2026 | Monday | News
Lonza Expands Bioprocessing Capabilities With Media Development Lab In Singapore
New media development services designed to optimize cell culture media development and identify robust, scalable media formulations driving cell culture performance and reliability The offering is ...
Lab
20 March, 2026 | Friday | News
Pace Life Sciences Advances Digital Laboratory Operations With Labguru Platform Integration
Cenevo’s Labguru platform is delivering a comprehensive solution to centralize documentation processes at Pace® Life Sciences, a U.S.-based contract development and manufacturing organi...
BioTech
20 March, 2026 | Friday | News
Excalipoint Therapeutics Secures 68.7 Million Dollar Seed Financing To Advance Next Generation T Cell Engager Platforms
Funding to advance proprietary T-cell engager platforms and pipeline of highly differentiated T-cell engager therapies targeting solid tumors and autoimmune diseases Financing co-led by multiple top-tier f...
Contract Services
20 March, 2026 | Friday | News
CellCarta And Biofidelity Expand Global Partnership With Exclusive Aspyre Lung Deployment In Clinical Trials
CellCarta and Biofidelity announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings. Building on their existing collaboration announced ...
Consumer Health
10 March, 2026 | Tuesday | News
China Clears IND For Harbour BioMed And Kelun Biotech Bispecific Antibody For Atopic Dermatitis
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, and Kelun-Biotech (6990.HK) today announced...
White Paper
20 March, 2026 | Friday | Analysis
Taiwan Strengthens Its Position In Asia’s Next Phase Of Bioprocessing Growth
Product Spot Light
11 March, 2026 | Wednesday | News
Waters Corporation Launches ARES G3 Rheometer To Accelerate Materials Research And Testing
Premium Article
15 December, 2025 | Tuesday | Report
APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
Bio Invest
25 March, 2026 | Wednesday | News
Thermo Fisher Accelerates Clinical Intelligence Leadership With Strategic Clario Acquisition
Biopharma APAC Infomercial
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
